A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine.
Naranjo
C A
CA
Addiction Research Foundation Clinical Institute, University of Toronto, Canada.
Lane
D
D
Ho-Asjoe
M
M
Lanctôt
K L
KL
D001499:Bayes Theorem; D006801:Humans; D016017:Odds Ratio; D011129:Polyradiculoneuropathy / Q000139:chemically induced* / Q000453:epidemiology; D011336:Probability; D013997:Time Factors; D015031:Zimeldine / Q000009:adverse effects*
D015031:Zimeldine